Sheila Breidinger

840 total citations
23 papers, 697 citations indexed

About

Sheila Breidinger is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Sheila Breidinger has authored 23 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 8 papers in Molecular Biology and 7 papers in Virology. Recurrent topics in Sheila Breidinger's work include HIV/AIDS drug development and treatment (13 papers), HIV Research and Treatment (7 papers) and Biosimilars and Bioanalytical Methods (4 papers). Sheila Breidinger is often cited by papers focused on HIV/AIDS drug development and treatment (13 papers), HIV Research and Treatment (7 papers) and Biosimilars and Bioanalytical Methods (4 papers). Sheila Breidinger collaborates with scholars based in United States, New Zealand and Germany. Sheila Breidinger's co-authors include Marian Iwamoto, Larissa Wenning, Julie A. Stone, John A. Wagner, Eric Woolf, Keith Gottesdiener, Neal Azrolan, Melanie Anderson, Bo Jin and Amelia S. Petry and has published in prestigious journals such as Analytical Chemistry, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Sheila Breidinger

23 papers receiving 674 citations

Peers

Sheila Breidinger
Gerry Rhodes United States
Gregory E. Chittick United States
Neil Buss Switzerland
Alieu Amara United Kingdom
Tsunefusa Hayashida Japan
Paul Savina United States
Aurélie Fayet Switzerland
Belle L. Lee United States
J. J. PLATTNER United States
Gerry Rhodes United States
Sheila Breidinger
Citations per year, relative to Sheila Breidinger Sheila Breidinger (= 1×) peers Gerry Rhodes

Countries citing papers authored by Sheila Breidinger

Since Specialization
Citations

This map shows the geographic impact of Sheila Breidinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheila Breidinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheila Breidinger more than expected).

Fields of papers citing papers by Sheila Breidinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheila Breidinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheila Breidinger. The network helps show where Sheila Breidinger may publish in the future.

Co-authorship network of co-authors of Sheila Breidinger

This figure shows the co-authorship network connecting the top 25 collaborators of Sheila Breidinger. A scholar is included among the top collaborators of Sheila Breidinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheila Breidinger. Sheila Breidinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Li, Yang Xu, Melanie Anderson, et al.. (2022). Incorporating protein precipitation to resolve hybrid IP-LC-MS assay interference for ultrasensitive quantification of intact therapeutic insulin dimer in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 212. 114639–114639. 1 indexed citations
2.
Anderson, Melanie, Marissa F. Dockendorf, Ian McIntosh, et al.. (2022). An Investigation of Instability in Dried Blood Spot Samples for Pharmacokinetic Sampling in Phase 3 Trials of Verubecestat. The AAPS Journal. 24(3). 52–52. 3 indexed citations
3.
Dockendorf, Marissa F., Melanie Anderson, Sheila Breidinger, et al.. (2022). A Model-Based Approach to Bridging Plasma and Dried Blood Spot Concentration Data for Phase 3 Verubecestat Trials. The AAPS Journal. 24(3). 53–53. 3 indexed citations
4.
Sun, Li, C.M. Chavez-Eng, Kerry L. Fillgrove, et al.. (2019). Toward Highly Sensitive and Reproducible LC–MS/MS Analysis of MK-8591 Phosphorylated Anabolites in Human Peripheral Blood Mononuclear Cells. Bioanalysis. 11(4). 233–250. 8 indexed citations
5.
Xu, Yang, Melanie Anderson, Ming Wang, et al.. (2018). Extractability-mediated stability bias and hematocrit impact: High extraction recovery is critical to feasibility of volumetric adsorptive microsampling (VAMS) in regulated bioanalysis. Journal of Pharmaceutical and Biomedical Analysis. 156. 58–66. 68 indexed citations
6.
Xu, Yang, et al.. (2018). Strategy for Peptide Quantification Using Lc–Ms in Regulated Bioanalysis: Case Study with a Glucose-Responsive Insulin. Bioanalysis. 10(15). 1207–1220. 5 indexed citations
7.
8.
Breidinger, Sheila, Richard C. Simpson, Eric Mangin, & Eric Woolf. (2015). Determination of suvorexant in human plasma using 96-well liquid–liquid extraction and HPLC with tandem mass spectrometric detection. Journal of Chromatography B. 1002. 254–259. 19 indexed citations
9.
Stroh, Mark, Punam Sandhu, Jacqueline B. McCrea, et al.. (2014). Lack of meaningful effect of ridaforolimus on the pharmacokinetics of midazolam in cancer patients: Model prediction and clinical confirmation. The Journal of Clinical Pharmacology. 54(11). 1256–1262. 4 indexed citations
10.
Stroh, Mark, John Palcza, Jacqueline B. McCrea, et al.. (2012). The effect of multiple doses of rifampin and ketoconazole on the single-dose pharmacokinetics of ridaforolimus. Cancer Chemotherapy and Pharmacology. 69(5). 1247–1253. 5 indexed citations
11.
Sun, Li, Hankun Li, Sheila Breidinger, et al.. (2012). Ultrasensitive Liquid Chromatography–Tandem Mass Spectrometric Methodologies for Quantification of Five HIV-1 Integrase Inhibitors in Plasma for a Microdose Clinical Trial. Analytical Chemistry. 84(20). 8614–8621. 26 indexed citations
12.
13.
Brainard, Diana M., Evan Friedman, Bo Jin, et al.. (2010). Effect of Low-, Moderate-, and High-Fat Meals on Raltegravir Pharmacokinetics. The Journal of Clinical Pharmacology. 51(3). 422–427. 44 indexed citations
14.
Jin, Bo, Sheila Breidinger, Steven D. Young, et al.. (2009). Pharmacokinetics of Raltegravir in Individuals With UGT1A1 Polymorphisms. Clinical Pharmacology & Therapeutics. 85(6). 623–627. 76 indexed citations
15.
16.
Iwamoto, Marian, Larissa Wenning, Bach‐Yen Nguyen, et al.. (2009). Effects of Omeprazole on Plasma Levels of Raltegravir. Clinical Infectious Diseases. 48(4). 489–492. 69 indexed citations
17.
Iwamoto, Marian, William D. Hanley, Amelia S. Petry, et al.. (2009). Lack of a Clinically Important Effect of Moderate Hepatic Insufficiency and Severe Renal Insufficiency on Raltegravir Pharmacokinetics. Antimicrobial Agents and Chemotherapy. 53(5). 1747–1752. 37 indexed citations
18.
Iwamoto, Marian, Larissa Wenning, Sheila Breidinger, et al.. (2008). Raltegravir Thorough QT/QTc Study: A Single Supratherapeutic Dose of Raltegravir Does Not Prolong the QTcF Interval. The Journal of Clinical Pharmacology. 48(6). 726–733. 39 indexed citations
19.
Iwamoto, Marian, Larissa Wenning, Goutam C. Mistry, et al.. (2008). Atazanavir Modestly Increases Plasma Levels of Raltegravir in Healthy Subjects. Clinical Infectious Diseases. 47(1). 137–140. 74 indexed citations
20.
Wenning, Larissa, Evan Friedman, James Kost, et al.. (2008). Lack of a Significant Drug Interaction between Raltegravir and Tenofovir. Antimicrobial Agents and Chemotherapy. 52(9). 3253–3258. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerry Rhodes Breakdown of academic impact, for papers by Gregory E. Chittick Breakdown of academic impact, for papers by Neil Buss Breakdown of academic impact, for papers by Alieu Amara Breakdown of academic impact, for papers by Tsunefusa Hayashida Breakdown of academic impact, for papers by Paul Savina Breakdown of academic impact, for papers by Aurélie Fayet Breakdown of academic impact, for papers by Belle L. Lee Breakdown of academic impact, for papers by J. J. PLATTNER
Rankless by CCL
2026